Björn Corleis

Dr. Björn Corleis serves as the Deputy Head of the Institute of Immunology (IfI) and leads the Laboratory for Mucosal Immunology and Vaccinology at the University of Greifswald, Germany. His research focuses on host-pathogen interactions, mucosal immunity, and vaccine development for infectious diseases.

• Education: PhD (University of London)

Dr. Corleis's research spans Immunology, Infectious Diseases, and Virology, with a particular emphasis on Mucosal Immunology, Vaccinology, and B Cell Biology. His work explores how environmental factors like tobacco smoke influence susceptibility to pathogens such as Mycobacterium tuberculosis and respiratory viruses.

Recent publications highlight his contributions to understanding H5N1 influenza dynamics in livestock, developing live-attenuated and mRNA vaccines for SARS-CoV-2, and investigating innate immune responses in tuberculosis. These studies often employ animal models and integrate genetic engineering with immunological profiling.

Dr. Corleis is affiliated with the Institute of Immunology (IfI) on the island of Riems, a hub for veterinary and immunological research. His collaborative projects frequently involve interdisciplinary teams across virology, immunology, and vaccine development.